Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chairman of the Board

Chief Operating Officer

CEO,CFO,Pres.,GC,Treas.,&Sec.

Chief Medical Officer

Chief Manufacturing Officer

CEO, President, Chairman

CFO, GC, Treasurer & Secretary

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead product candidates include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric and gynecologic cancers; and FL-301, a monoclonal antibody that targets cells that express Claudin18.2 on their cell surface and is in phase I clinical trial, as well as two preclinical antibody programs, FL-302 and FL-501. Leap Therapeutics, Inc. has an option and license agreement with BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-01-26	Premium	acquired	Premium	Premium	Premium	Chairman of the Board
2024-01-26	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2024-01-26	Premium	acquired	Premium	Premium	Premium	CEO,CFO,Pres.,GC,Treas.,&Sec.
2024-01-26	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-01-26	Premium	acquired	Premium	Premium	Premium	Chief Manufacturing Officer
2023-03-17	Premium	acquired	Premium	Premium	Premium	CEO,CFO,Pres.,GC,Treas.,&Sec.
2021-09-24	Premium	bought	Premium	Premium	Premium	-
2020-12-28	Premium	sold	Premium	Premium	Premium	-
2020-06-22	Premium	bought	Premium	Premium	Premium	-
2019-02-05	Premium	bought	Premium	Premium	Premium	CEO, President, Chairman
2019-02-05	Premium	bought	Premium	Premium	Premium	Chief Operating Officer
2019-02-05	Premium	bought	Premium	Premium	Premium	CFO, GC, Treasurer & Secretary
2019-02-05	Premium	bought	Premium	Premium	Premium	-

LPTX - Leap Therapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for LPTX